Cancer cells are preferentially killed by anticancer agents because key signals for growth and cell division are "always on" as opposed to the alternative "on" and "off" signaling of normal cells. Too much of today's anticancer drug discovery effort may go toward reversing genetically promoted "always on" signals. More effective anticancer drug targets may be found through use of RNAi technolog...

Cancer is an important area of interest in the life sciences because it has been a major killer disease throughout human history. Heterocyclic molecules are well known to play a critical role in health care and pharmaceutical drug design. Currently a number of heterocyclic compounds are available commercially as anticancer drugs and great efforts have been put to the identification of novel ant...

Research on the therapeutic applications of calixarene derivatives is an emerging area of interest. The anticancer activity of various functionalized calixarenes has been reported by several research groups. Due to their superior geometric shape, calixarenes can accommodate drug molecules by forming inclusion complexes. Controlled release of anticancer drugs by calixarenes might help in targete...

The investigation of potential self-assembled peptides as carriers for the anticancer drug Bortezomib delivery is topic present study. self-assembly in water examined using...

In this study, we reported a method to associate doxorubicin drug on folic acid functionalized SiO2/ZnO nanoparticles (NPs) in rod and spherical shapes. The clinical usage of the anticancer drug, doxorubicin (DOX), is limited by severe side effects and cell resistance. Targeted drug delivery by binding DOX to nanoparticles could overcome these limitations. The surface functionalization of the Z...

Since the past decade, drug shortage is becoming the major concern for pharmaceutical markets and it is even more in case of anticancer drugs [1,2]. Comparatively very less number of anticancer drugs is available in the current markets and various factors affecting shortage can be attributed to every stage such as drug discovery, development, conducting clinical trials and design of generic dru...

ABSTRACT This paper presents the in situ quantitative monitoring of the anticancer drug doxorubicin (DOX) efflux from the drug resistant lung cancer cells NCI-H69AR by using a microelectrode array integrated compact electrochemical system. This approach achieves a sensitive, quantitative, non invasive and real-time efflux assay that can help address drug resistance, a major therapeutic stumblin...